Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Arginase-1 mRNA expression correlates with myeloid-derived suppressor cell levels in peripheral blood of NSCLC patients.

Lung cancer (Amsterdam, Netherlands) - 1 Sept 2013

Heuvers Marlies E, Muskens Femke, Bezemer Koen, Lambers Margaretha, Dingemans Anne-Marie C, Groen Harry J M, Smit Egbert F, Hoogsteden Henk C, Hegmans Joost P J J, Aerts Joachim G J V

Abstract excerpt

Myeloid-derived suppressor cells (MDSC) are a heterogeneous population of immature and progenitor myeloid cells with immunosuppressive activity that are increased in cancer patients. Until now, the characterization of MDSC in humans was very challenging. The aim of this study was to determine the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Arginase
Share to Cryopreservation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunophenotyping

Share to Leukocyte Count

Share to Leukocytes, Mononuclear

Share to Lymphocyte Count

Share to Myeloid Cells

Share to T-Lymphocyte Subsets

Source

Identifiers

PMID: 23850196
DOI: 10.1016/j.lungcan.2013.06.005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Prepared record publication-23850196-2026-09-05.1. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Arginase-1 mRNA expression correlates with myeloid-derived suppressor cell levels in peripheral blood of NSCLC patients.PMID 23850196Read ↗

Myeloid-Derived Suppressor Cells in Solid TumorsSemantic proximity Read ↗

Clinical Relevance and Suppressive Capacity of Human Myeloid-Derived Suppressor Cell SubsetsSemantic proximity Read ↗

Accumulation of circulating myeloid-derived suppressor cell subsets: predicting poor clinical efficacy and prognosis through T cell suppression in non-Hodgkin's lymphomaSemantic proximity Read ↗

Myeloid-Derived Suppressor Cells.Semantic proximity Read ↗

Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment.Semantic proximity Read ↗

Complexity and challenges in defining myeloid-derived suppressor cellsSemantic proximity Read ↗

Complexity and challenges in defining myeloid-derived suppressor cellsSemantic proximity Read ↗

Detection of myeloid-derived suppressor cells by flow cytometry.Semantic proximity Read ↗

Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity.Semantic proximity Read ↗

Phenotypes, accumulation, and functions of myeloid-derived suppressor cells and associated treatment strategies in cancer patients.Semantic proximity Read ↗

The diversity of circulating neutrophils in cancer.Semantic proximity Read ↗

A novel subset of B7-H3<sup>+</sup>CD14<sup>+</sup>HLA-DR<sup>−/low</sup>myeloid-derived suppressor cells are associated with progression of human NSCLCSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.